This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Atm reactivation reverses ataxia telangiectasia phenotypes in vivo
Cell Death & Disease Open Access 22 February 2018
-
Ataxia telangiectasia: a review
Orphanet Journal of Rare Diseases Open Access 25 November 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fbmt.2012.207/MediaObjects/41409_2013_Article_BFbmt2012207_Fig1_HTML.jpg)
References
Swift M, Morrell D, Cromartie E, Chamberlin AR, Skolnick MH, Bishop DT . The incidence and gene frequency of ataxia-telangiectasia in the United States. Am J Hum Genet 1986; 39: 573–583.
Swift M, Morrell D, Massey RB, Chase CL . Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 1991; 325: 1831–1836.
Seidemann K, Henze G, Beck JD, Sauerbrey A, Kühl J, Mann G et al. Non-Hodgkin's lymphoma in pediatric patients with chromosomal breakage syndromes (AT and NBS): experience from the BFM trials. Ann Oncol 2000; 11 (Suppl 1): 141–145.
Bienemann K, Burkhardt B, Modlich S, Meyer U, Möricke A, Bienemann K et al. Promising therapy results for lymphoid malignancies in children with chromosomal breakage syndromes (ataxia teleangiectasia or Nijmegen-breakage syndrome): a retrospective survey. Br J Haematol 2011; 155: 468–476.
Broccoletti T, Del Giudice E, Cirillo E, Vigliano I, Giardino G, Ginocchio VM et al. Efficacy of very-low-dose betamethasone on neurological symptoms in ataxia-telangiectasia. Eur J Neurol 2011; 18: 564–570.
EBMT/ESID guidelines for hematopoieic stem cell transplantation for primary immunodeficiencies. 2011, http://www.esid.org/downloads/BMT_Guidelines_2011.pdf.
Ghosh S, Schuster FR, Binder V, Niehues T, Baldus SE, Seiffert P et al. Fatal outcome despite full lympho-hematopoietic reconstitution after allogeneic stem cell transplantation in atypical ataxia telangiectasia. J Clin Immunol 2012; 32: 438–440.
Albert MH, Gennery AR, Greil J, Cale CM, Kalwak K, Kondratenko I et al. Successful SCT for Nijmegen breakage syndrome. Bone Marrow Transplant 2010; 45: 622–626.
Acknowledgements
We thank Dr Thilo Dörk-Bousset from the Hannover Medical School for providing help with A-T diagnostics.
Author Contribution: Design, data analysis and manuscript writing were performed by MU and KK. Data collection was done by JM. Drafting and critical revision of the paper were performed by JM, ED and OH. Genetic analysis was carried out by ED and OH.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Ussowicz, M., Musiał, J., Duszeńko, E. et al. Long-term survival after allogeneic-matched sibling PBSC transplantation with conditioning consisting of low-dose busilvex and fludarabine in a 3-year-old boy with ataxia-telangiectasia syndrome and ALL. Bone Marrow Transplant 48, 740–741 (2013). https://doi.org/10.1038/bmt.2012.207
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2012.207